Nutex Health Files 8-K: Other Events & Financials
Ticker: NUTX · Form: 8-K · Filed: Feb 6, 2025 · CIK: 1479681
Sentiment: neutral
Topics: 8-K, filing, financials
Related Tickers: NUTX
TL;DR
NUTX filed an 8-K on Feb 5th covering other events and financials.
AI Summary
Nutex Health, Inc. filed an 8-K on February 6, 2025, reporting other events and financial statements as of February 5, 2025. The company, formerly known as Clinigence Holdings, Inc. and iGambit, Inc., is incorporated in Delaware and headquartered in Houston, Texas.
Why It Matters
This filing provides updates on significant events and financial information for Nutex Health, Inc., which could impact investor understanding of the company's current status.
Risk Assessment
Risk Level: low — This is a routine filing of an 8-K, indicating no immediate or significant new risks are disclosed.
Key Players & Entities
- Nutex Health, Inc. (company) — Registrant
- Clinigence Holdings, Inc. (company) — Former company name
- iGambit, Inc. (company) — Former company name
- February 5, 2025 (date) — Date of earliest event reported
- February 6, 2025 (date) — Filing date
FAQ
What is the primary purpose of this 8-K filing?
This 8-K filing is for reporting 'Other Events' and 'Financial Statements and Exhibits' as of February 5, 2025.
What was Nutex Health, Inc. previously known as?
Nutex Health, Inc. was formerly known as Clinigence Holdings, Inc. and iGambit, Inc.
In which state is Nutex Health, Inc. incorporated?
Nutex Health, Inc. is incorporated in Delaware.
What is the principal executive office address for Nutex Health, Inc.?
The principal executive office is located at 6030 S. Rice Ave, Suite C, Houston, Texas 77081.
What is the filing date of this 8-K report?
This 8-K report was filed on February 6, 2025.
Filing Stats: 448 words · 2 min read · ~1 pages · Grade level 9.6 · Accepted 2025-02-05 20:14:39
Key Financial Figures
- $0.001 — ch registered Common Stock, par value $0.001 NUTX The NASDAQ Stock Market LLC
Filing Documents
- nutx_8k-020525.htm (8-K) — 21KB
- ex99x1.htm (EX-99.1) — 8KB
- 0001079973-25-000190.txt ( ) — 228KB
- nutx-20250205.xsd (EX-101.SCH) — 3KB
- nutx-20250205_def.xml (EX-101.DEF) — 26KB
- nutx-20250205_lab.xml (EX-101.LAB) — 33KB
- nutx-20250205_pre.xml (EX-101.PRE) — 22KB
- nutx_8k-020525_htm.xml (XML) — 4KB
01 Other Events
Item 8.01 Other Events. On February 5, 2025, Nutex Health Inc. (the "Company") issued a press release entitled "Nutex Health Issues No Surprises Act (NSA) Arbitration Update". A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated by reference into this Item 8.01.
Financial Statements and Exhibits
Financial Statements and Exhibits (d) Exhibits Exhibit No. Description of Exhibit 99.1 Press release dated February 5, 2025 104 Cover Page Interactive Data File - the cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized. Dated: February 5, 2025 NUTEX HEALTH INC. By: /s/ Jon C. Bates Jon C. Bates Chief Financial Officer